Mangoceuticals (MGRX) Price to Book (2023 - 2026)

Mangoceuticals has disclosed Price to Book across 4 years of filings, most recently posting 0.55 for Q2 2026.

• In Q2 2026, Price to Book fell 35.0% year-over-year to 0.55; the TTM figure through Jun 2026 stood at 0.55 (down 35.0% YoY), while the FY2025 annual figure was 0.49, up 42.77% from the prior year.
• Price to Book came in at 0.55 for Q2 2026 at Mangoceuticals, up from 0.45 in the prior quarter.
• In the past five years, Price to Book ranged from a high of 10.54 in Q3 2023 to a low of 5.35 in Q1 2024.
• Average Price to Book over 4 years is 2.17, with a median of 0.59 recorded in 2024.
• Year-over-year, Price to Book tumbled 259.08% in 2024 and surged 193.64% in 2025.
• Over 4 years, Price to Book stood at 5.76 in 2023, then plunged by 94.04% to 0.34 in 2024, then surged by 42.77% to 0.49 in 2025, then gained by 11.48% to 0.55 in 2026.
• Per Business Quant data, the three most recent Price to Book figures were 0.55 in Q2 2026, 0.45 in Q1 2026, and 0.49 in Q4 2025.